Keenova Therapeutics plc MNKTQ (last ticker on record)

CIK 1567892Its SEC filings (opens in a new tab)

SEC/DOJ scrutiny
95% wipeout
Bankruptcy
Delisting notice (not a red flag)
Restructuring

These figures describe clients, not conduct. A lawyer or firm can serve many companies that later had trouble for reasons that have nothing to do with their work, and nothing here says any lawyer or firm did anything wrong.

Red flags: 4; Newest began Aug 2025
Largest fall in its shares: 99%; Mar 2015 to Oct 2020
Law firms: 10; Linked to 5 or more companies
Lawyers: 24; Linked to 5 or more companies

What happened

Aug 1, 2025Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Dec 5, 2024Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Jan 9, 2024Exit or disposal costs (Item 2.05)Form 8-K (opens in a new tab)
Nov 13, 2023Bankruptcy or receivership (Item 1.03)Form 8-K (opens in a new tab)
Oct 10, 2023Bankruptcy or receivership (Item 1.03)Form 8-K (opens in a new tab)
Aug 29, 2023Delisting notice (Item 3.01)Form 8-K (opens in a new tab)
Aug 28, 2023Bankruptcy or receivership (Item 1.03)Form 8-K (opens in a new tab)
Aug 28, 2023Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Jul 18, 2023Shares down 95% from their high
Jul 17, 2023Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Jun 20, 2023Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Jun 15, 2023Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Mar 3, 2023A filing mentions a Wells noticeForm 10-K (opens in a new tab)
Jul 1, 2022Bankruptcy or receivership (Item 1.03)Form 8-K/A (opens in a new tab)
May 3, 2022Bankruptcy or receivership (Item 1.03)Form 8-K (opens in a new tab)
Mar 10, 2021A filing mentions an SEC subpoenaForm 10-K (opens in a new tab)
Oct 13, 2020Bankruptcy or receivership (Item 1.03)Form 8-K (opens in a new tab)
Oct 13, 2020Debt accelerated (Item 2.04)Form 8-K (opens in a new tab)
Oct 13, 2020Delisting notice (Item 3.01)Form 8-K (opens in a new tab)
Nov 5, 2019A filing mentions cooperating with the SECForm 10-Q (opens in a new tab)
Nov 5, 2019A filing mentions an SEC subpoenaForm 10-Q (opens in a new tab)
Aug 1, 2019Shares down 95% from their high
Feb 27, 2018A filing mentions a grand jury subpoenaForm 10-K (opens in a new tab)
Aug 8, 2017A filing mentions an SEC subpoenaForm 10-Q (opens in a new tab)
May 8, 2017A filing mentions an SEC subpoenaForm 10-Q (opens in a new tab)

An SEC release can name a company’s officer, or its stock as what a scheme sold or moved, so the company may be the victim. Each link goes to what to read.

Law firms

The ratios are about all the companies linked to each one, this one included: how many had that outcome, as a multiple of what comparable companies show. 1.00 means no more than expected.

Law firms linked to this company
Name	First linked	How it is known	Linked companies	SEC/DOJ scrutiny	Went dark	95% wipeout
Hogan Lovells US LLP	Aug 2025	Named in a filing	487	0.96	0.26	0.85
Davis Polk	Apr 2025	Named in SEC correspondence	1,694	1.26	0.06	1.02
Latham & Watkins LLP	May 2014	Named in SEC correspondence	2,667	0.98	0.31	1.10
Allen & Overy	May 2013	Named in a filing	244	1.00	0.36	0.66
Arthur Cox	May 2013	Named in a filing	92	0.68	0.43	0.91
Wachtell Lipton Rosen & Katz	Feb 2013	Named in SEC correspondence	889	1.31	0.07	0.59
A&L Goodbody	Apr 2025	Text search only	85	1.14	0.00	0.56
Paul Weiss Rifkind Wharton & Garrison	Apr 2025	Text search only	826	1.02	0.18	0.83
Sidley Austin	May 2013	Text search only	1,210	1.30	0.14	0.93
Skadden, Arps, Slate, Meagher & Flom LLP	Feb 2013	Text search only	2,607	1.15	0.19	0.85

Lawyers

The ratios are about all the companies linked to each one, this one included: how many had that outcome, as a multiple of what comparable companies show. 1.00 means no more than expected.

Lawyers linked to this company
Name	First linked	How it is known	Linked companies	SEC/DOJ scrutiny	Went dark	95% wipeout
William I. IntnerHogan Lovells US LLP	Aug 2025	Named in a filing	31	0.58	0.00	1.15
Michael DavisDavis Polk	Apr 2025	Named in SEC correspondence	25	0.57	0.00	0.65
Michael KaplanDavis Polk	Apr 2025	Named in SEC correspondence	112	1.20	0.00	0.89
Joel H. TrotterLatham & Watkins LLP	Jun 2014	Named in SEC correspondence	35	1.04	0.00	0.74
R. Scott SheanLatham & Watkins LLP	May 2014	Named in SEC correspondence	37	1.95	0.74	0.78
Marc FeiderAllen & Overy	Mar 2014	Named in a filing	7	1.70	0.00	1.09
Victor GoldfeldWachtell Lipton Rosen & Katz	Feb 2013	Named in SEC correspondence	29	1.27	0.00	0.44
Adam O. EmmerichWachtell Lipton Rosen & Katz	Feb 2013	Named in a filing	91	1.14	0.00	0.67
Benjamin M. RothWachtell Lipton Rosen & Katz	Feb 2013	Named in SEC correspondence	54	1.66	0.00	0.54
Benjamin D. SternLatham & Watkins LLP	Apr 2025	Text search only	6	0.00	0.00	0.00
Chelsea N. DarnellPaul Weiss Rifkind Wharton & Garrison	Apr 2025	Text search only	8	3.53	0.00	0.00
ANDREW R. BROWNSTEINWachtell Lipton Rosen & Katz	Jun 2013	Text search only	117	1.36	0.00	0.49
David A. KatzWachtell Lipton Rosen & Katz	Jun 2013	Text search only	108	1.44	0.00	0.70
David K. LamWachtell Lipton Rosen & Katz	Jun 2013	Text search only	110	1.17	0.00	0.52
Edward D. HerlihyWachtell Lipton Rosen & Katz	Jun 2013	Text search only	148	1.03	0.00	0.43
Sabastian V. Niles	May 2013	Text search only	24	1.35	0.00	1.30
Adam J. ShapiroDavis Polk	Feb 2013	Text search only	26	1.35	0.00	0.95
Daniel A. NeffWachtell Lipton Rosen & Katz	Feb 2013	Text search only	75	1.42	0.00	0.82
ERIC S. ROBINSONWachtell Lipton Rosen & Katz	Feb 2013	Text search only	34	1.87	0.00	1.23
Gregory E. OstlingWachtell Lipton Rosen & Katz	Feb 2013	Text search only	44	1.11	0.00	0.52
Lawrence S. MakowWachtell Lipton Rosen & Katz	Feb 2013	Text search only	45	1.74	0.00	0.92
Matthew M. GuestWachtell Lipton Rosen & Katz	Feb 2013	Text search only	67	1.18	0.00	0.50
Nicholas G. DemmoWachtell Lipton Rosen & Katz	Feb 2013	Text search only	62	1.60	0.00	0.85
Steven A. RosenblumWachtell Lipton Rosen & Katz	Feb 2013	Text search only	55	1.65	0.00	0.39